For those most impacted and waiting for justice, 2025 can be a year of accountability. Here are two databases to track the settlement money ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgery or injury, the ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...

Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...